NCT06134830Not yet recruiting
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
Clinical Outcome and Quality of Life in Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
Source: ClinicalTrials.gov · Last updated 6 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Determine the frequency of utilizing single and multiple doses of radioactive iodine (RAI) in treatment of differentiated thyroid cancer. 2. Asses the impact of various doses of radioactive iodine on the management of differentiated thyroid cancer. 3. Investigate the influence of thyroid cancer on the quality of life of affected patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 13 Nov 2023
- Start date
- 1 Mar 2024
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Assiut University
- Diseases
- Thyroid cancer, Childhood cancers
- NCT number
- NCT06134830
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Mar 2024 to the primary completion date, 1 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- • Missed follow up data.
Who the study is looking for
- • Patients with differentiated cancer thyroid either papillary or follicular underwent total thyroidectomy with or without lymph node dissection.
- Available data of patients' records.
Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.